Home
Advertisement & Sponsorship Options
2021/22 Media Kit
Continued Medical Education
Cancer A – Z
Drug Developmemt Technologies
A Novel Technology based on Somatic Hypermutation (SHM)
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
The Network
The Episodes
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
The Onco’Zine Brief
The Episodes
National Advertising
Agenda
Directory
Join Today
Event Agenda
Video
Careers
Search
About
Advertise
Advisory Board
Contact Us
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Onco'Zine
Advertisement #1
Home
Advertisement & Sponsorship Options
2021/22 Media Kit
Continued Medical Education
Cancer A – Z
Drug Developmemt Technologies
A Novel Technology based on Somatic Hypermutation (SHM)
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
The Network
The Episodes
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
The Onco’Zine Brief
The Episodes
National Advertising
Agenda
Directory
Join Today
Event Agenda
Video
Careers
Home
Clinical development
Phase II
Phase II
Phase II
Investigational Therapy Shows Promise Against Viral Infections After Stem Cell Transplant
Editorial Team
-
January 11, 2023
Phase 2b Study Investigates NFX-179 for the Treatment of Cutaneous Neurofibromas
Adagrasib Receives Breakthrough Therapy Designation for Advanced, KRAS-Mutated Colorectal Cancer
Combination Treatments in Patients with Myeloproliferative Neoplasms Reduce Burden of Disease
Potential Chemotherapy-free option in HER2+/HR+ mBC with Zanidatamab + Palbociclib + Fulvestrant
SERENA-2 Study Show Potential of Camizestrant as a Next-generation SERD in...
Danielle Garcia
-
December 8, 2022
Treatment Guided by CTC Count May Improve Long-term Outcomes in Patients...
Editorial Team
-
December 8, 2022
Sermonix to Present Four Posters During the 2022 San Antonio Breast...
Danielle Garcia
-
November 17, 2022
Jazz Pharmaceuticals and Zymeworks Agree to Jointly Develop and Commercialize Zanidatamab
Danielle Garcia
-
October 19, 2022
Osimertinib + Savolitinib Demonstrated 49% ORR in Lung Cancer Patients with...
Editorial Team
-
August 9, 2022
Activity of Tivozanib in Non-Clear Cell RCC Subgroups: a Phase 2...
Editorial Team
-
July 7, 2022
US FDA Grants Priority Review for the CD20xCD3 T-cell Engaging Bispecific...
Editorial Team
-
July 6, 2022
FDA Grants Fast Track Designation for VAL-083 for the Treatment of...
Danielle Garcia
-
June 15, 2022
Biomarkers Predict Better Immunotherapy Treatment Outcomes for Patients with Pancreatic Cancer
Danielle Garcia
-
June 6, 2022
Encouraging Results for Cabozantinib Mono- and Combination Therapy Across Different Tumor...
Danielle Garcia
-
June 6, 2022
1
2
3
...
5
Page 1 of 5
LATEST NEWS
US FDA Approves Gilead’s Sacituzumab Govitecan In Pre-treated HR+/HER2- Metastatic Breast Cancer
Editorial Team
-
February 3, 2023
World health Organization Launches a New Global Breast Cancer Initiative
Editorial Team
-
February 3, 2023
A New Design Improves CAR-based Immunotherapies
Editorial Team
-
February 2, 2023
Study: Blocking Immune Suppressor Cells in Mice with Glioblastoma Improves Survival
Danielle Garcia
-
January 27, 2023
Stephen Spellman: Mismatched Unrelated Donors – Key to Erasing the Gap in Donor Availability...
Editorial Team
-
January 18, 2023
X